International Medical released its 2026 interim report, with net profit attributable to the parent company showing a loss of 65.32 million yuan. Total operating revenue was 2.032 billion yuan, down 0.11 percent from the same period last year. Net cash inflow from operating activities was 493 million yuan, down 16.72 percent year on year. The company's latest asset-liability ratio was 68.54 percent, gross margin was 12.58 percent, return on equity was negative 2.01 percent, and diluted earnings per share was negative 0.03 yuan.
Xian International Medical Investment Co LtdNet loss of 65.32 million yuan in interim report